van Drie John H
Vertex Pharmaceuticals, 130 Waverly St., Cambridge, MA 02139, USA.
Curr Pharm Des. 2003;9(20):1649-64. doi: 10.2174/1381612033454568.
Pharmacophore discovery is one of the major elements of molecular modeling in the absence of X-ray structural data. While pharmacophores initially made their debut as a means for lead discovery, more recent refinements have brought them into the domain of lead optimization, e.g. as a means to define the molecular alignment in 3D-QSAR. In this review, the experiences of over a decade of confronting and solving the challenges of pharmacophore discovery applied to actual drug discovery are summarized. Also, practical tips are described for using the author's methodology for pharmacophore discovery, DANTE.
在缺乏X射线结构数据的情况下,药效团发现是分子建模的主要要素之一。虽然药效团最初作为先导化合物发现的一种手段首次亮相,但最近的改进已将它们带入先导化合物优化领域,例如作为在3D-QSAR中定义分子排列的一种手段。在本综述中,总结了十多年来在实际药物发现中面对和解决药效团发现挑战的经验。此外,还描述了使用作者的药效团发现方法DANTE的实用技巧。